Protara Therapeutics, Inc. · NASDAQ:TARA
BlackRock, Inc. reported a 6.30% stake in Protara Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 27, 2026
BlackRock, Inc. reported a 6.30% stake in Protara Therapeutics, Inc., 3,387,459 shares, as a passive investor on Mar 31, 2026. Filed Apr 27, 2026 (Schedule 13G).
- Stake
- 6.30%
- Shares
- 3,387,459
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.30% | 3,387,459 |
Source
Related
- Protara Therapeutics, Inc.
- BlackRock, Inc.
- Protara Therapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jan 21, 2026
- Schedule 13G · BlackRock, Inc. · Jul 17, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Schedule 13G/A · Millennium Management LLC · Jul 7, 2026
- Form 4 · Shefferman Jesse · Jul 1, 2026
- Form 4 · Conkling William · Jun 3, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026